Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19

In January 2020, Chinese health agencies reported an outbreak of a novel coronavirus-2 (CoV-2) which can lead to severe acute respiratory syndrome (SARS). The virus, which belongs to the coronavirus family (SARS-CoV-2), was named coronavirus disease 2019 (COVID-19) and declared a pandemic by the Wor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Santosh, Zhi, Kaining, Mukherji, Ahona, Gerth, Kelli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290948/
https://www.ncbi.nlm.nih.gov/pubmed/32357553
http://dx.doi.org/10.3390/v12050486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290948/
https://www.ncbi.nlm.nih.gov/pubmed/32357553
http://dx.doi.org/10.3390/v12050486

Ejemplares similares